<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HAA96278F957A4FBD8FEDA3DE74BF233E" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 5278 IH: Affordable Inhalers and Nebulizers Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-09-10</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 5278</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250910">September 10, 2025</action-date><action-desc><sponsor name-id="M000687">Mr. Mfume</sponsor> (for himself, <cosponsor name-id="J000288">Mr. Johnson of Georgia</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="T000488">Mr. Thanedar</cosponsor>, <cosponsor name-id="E000301">Ms. Elfreth</cosponsor>, <cosponsor name-id="M001229">Mrs. McIver</cosponsor>, <cosponsor name-id="F000110">Mr. Fields</cosponsor>, <cosponsor name-id="D000096">Mr. Davis of Illinois</cosponsor>, <cosponsor name-id="F000481">Mr. Figures</cosponsor>, <cosponsor name-id="O000176">Mr. Olszewski</cosponsor>, <cosponsor name-id="I000058">Mr. Ivey</cosponsor>, and <cosponsor name-id="M001232">Mrs. McClain Delaney</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committees on <committee-name committee-id="HWM00">Ways and Means</committee-name>, and <committee-name committee-id="HED00">Education and Workforce</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to reduce patient cost sharing for prescription drug inhaler products used to treat breathing disorders such as asthma and chronic obstructive pulmonary disease, and for other purposes.</official-title></form><legis-body id="HE9155750226041CC811D38FE5E820E64" style="OLC"><section id="H16CA4528D2F14ABDAF920AB37BEF6C49" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Affordable Inhalers and Nebulizers Act of 2025</short-title></quote>.</text></section><section id="H43D739FC5B8B4E7A8EF661ADEC48C94D"><enum>2.</enum><header>Reducing patient cost sharing for prescription drug inhaler products used to treat breathing disorders such as asthma and chronic obstructive pulmonary disease</header><subsection id="H7D999C209BC94455B1B3A5DF536A5B02"><enum>(a)</enum><header>Coverage and cost-Sharing requirements</header><paragraph id="H19F5967F515F44DA90A2239BE93D42F5"><enum>(1)</enum><header>Private insurance</header><subparagraph id="H430271CC3F6D4BB0828EBC6283ECF0CC"><enum>(A)</enum><header>PHSA</header><text display-inline="yes-display-inline">Part D of title XXVII of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300gg-111">42 U.S.C. 300gg–111 et seq.</external-xref>) is amended by adding at the end the following new section:</text><quoted-block style="OLC" id="H7D348B06E47443B39A12490344D61C09" display-inline="no-display-inline"><section id="H3677C95F649940B08DA18C376D9A925F"><enum>2799A–11.</enum><header>Coverage and cost-sharing requirements for specified inhaler
 products</header><subsection id="H16283AC775A04D699C5D46DB2B56C9CD"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall provide benefits under such plan or coverage (as applicable) for all specified inhaler products and, with respect to such a product, may not—</text><paragraph id="H9E36FF9001E7401B951D0833F46BE272"><enum>(1)</enum><text>apply any deductible; or</text></paragraph><paragraph id="HC9788649F1B7462FA686BBD264232437"><enum>(2)</enum><text>impose any cost-sharing requirement in excess of $15 per 30-day supply of such product.</text></paragraph></subsection><subsection id="H5C329E4FFC2B48C69EB3F22F4B5F4752"><enum>(b)</enum><header>Counting cost sharing towards deductible and out-of-Pocket
 maximum</header><text display-inline="yes-display-inline">A group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall count any cost-sharing requirement described in subsection (a)(2) incurred by an individual enrolled under such plan with respect to a specified inhaler product towards any out-of-pocket maximum and any deductible that, but for application of subsection (a), would have applied to such individual and product.</text></subsection><subsection id="H4872AA0FAB1341A9B3CEC66A5403CBC2"><enum>(c)</enum><header>Specified inhaler product defined</header><text display-inline="yes-display-inline">For purposes of this section, the term <term>specified inhaler product</term> means any maintenance or reliever or rescue inhalation drug (including inhalation aerosols, metered dose inhalers, dry powder inhalers, inhalation solutions, bronchodilators, and corticosteroids) with a medically accepted indication (as defined in section 1927(k)(6)) for the treatment for lung diseases such as asthma and chronic obstructive pulmonary disease. Such term includes any equipment used in the administration of such drug (such as masks and tubing, spacers, nebulizers, and valve-holding chambers).</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph><subparagraph id="HAC9DDD71DE4641EC8FE33B3A24B9F316"><enum>(B)</enum><header>IRC</header><clause id="HFD9B514A0222492DAEA2735FECCC90A7"><enum>(i)</enum><header>In general</header><text display-inline="yes-display-inline">Subchapter B of <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/26/100">chapter 100</external-xref> of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:</text><quoted-block style="OLC" id="HCC9BA86B18CC4B81B9920DD45C655CFD" display-inline="no-display-inline"><section id="H5105795DDAEF4FAE94895A9A88424DA5"><enum>9826.</enum><header>Coverage and cost-sharing requirements for specified inhaler
 products</header><subsection id="H697433A1272548AAA7DE3D73BBA4A152"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">A group health plan shall provide benefits under such plan for all specified inhaler products and, with respect to such a product, may not—</text><paragraph id="HF3B581434A8445C2937772EC4729A7F8"><enum>(1)</enum><text>apply any deductible; or</text></paragraph><paragraph id="HE5F29A69151244BEAB6F9163E1299C58"><enum>(2)</enum><text>impose any cost-sharing requirement in excess of $15 per 30-day supply of such product.</text></paragraph></subsection><subsection id="H66E824A1AED74A1E8DF9F2C9640C41A7" display-inline="no-display-inline"><enum>(b)</enum><header>Counting cost sharing towards deductible and out-of-Pocket
 maximum</header><text display-inline="yes-display-inline">A group health plan shall count any cost-sharing requirement described in subsection (a)(2) incurred by a participant or beneficiary of such plan with respect to a specified inhaler product towards any out-of-pocket maximum and any deductible that, but for application of subsection (a), would have applied to such participant or beneficiary.</text></subsection><subsection id="HF226FA9A72D647EDBFC01A70D9BF345E"><enum>(c)</enum><header>Specified inhaler product defined</header><text display-inline="yes-display-inline">For purposes of this section, the term <term>specified inhaler product</term> means any maintenance or reliever or rescue inhalation drug (including inhalation aerosols, metered dose inhalers, dry powder inhalers, inhalation solutions, bronchodialators, and corticosteroids) with a medically accepted indication (as defined in section 1927(k)(6)) for the treatment of asthma or of chronic obstructive pulmonary disease. Such term includes any equipment used in the administration of such drug (such as masks and tubing, spacers, nebulizers, and valve-holding chambers).</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></clause><clause id="H93150E1A8AE348729C1B9924CBD451EB" display-inline="no-display-inline"><enum>(ii)</enum><header>Clerical amendment</header><text>The table of sections for such subchapter is amended by adding at the end the following new item:</text><quoted-block style="OLC" id="HC540B7F219FB4B028C731383C00A068D"><toc regeneration="no-regeneration"><toc-entry level="section">Sec. 9826. Coverage and cost-sharing requirements for
 specified inhaler products.</toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></clause></subparagraph><subparagraph id="HDEEB301CCC7F45708235761A448C8185"><enum>(C)</enum><header>ERISA</header><clause id="H0B5F2E82726241B4970A6D2C2C3285F6"><enum>(i)</enum><header>In general</header><text display-inline="yes-display-inline">Subpart B of part 7 of subtitle B of title I of the Employee Retirement Income Security Act of 1974 is amended by adding at the end the following new section:</text><quoted-block style="OLC" id="HF4A5519AC4D248818A47ED2C5E0C6193" display-inline="no-display-inline"><section id="H05912C17EBEC4DABA7E7039B96BD60C1"><enum>726.</enum><header>Coverage and cost-sharing requirements for specified inhaler
 products</header><subsection id="H4D7D9F81659748D2AB00DA96F2E46BC0"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">A group health plan, and a health insurance issuer offering group health insurance coverage, shall provide benefits under such plan or coverage (as applicable) for all specified inhaler products and, with respect to such a product, may not—</text><paragraph id="H4C98DA945DBE47F2B92851E5EEE7FAAD"><enum>(1)</enum><text>apply any deductible; or</text></paragraph><paragraph id="HC97CB803A3EE4B48940B66F94383CDEB"><enum>(2)</enum><text>impose any cost-sharing requirement in excess of $15 per 30-day supply of such product.</text></paragraph></subsection><subsection id="H8B85519679D8427AB84B89AD0CABFA25" display-inline="no-display-inline"><enum>(b)</enum><header>Counting cost sharing towards deductible and out-of-Pocket
 maximum</header><text display-inline="yes-display-inline">A group health plan, and a health insurance issuer offering group health insurance coverage, shall count any cost-sharing requirement described in subsection (a)(2) incurred by a participant or beneficiary of such plan with respect to a specified inhaler product towards any out-of-pocket maximum and any deductible that, but for application of subsection (a), would have applied to such participant or beneficiary and product.</text></subsection><subsection id="H4BE6078D6B60493BA65F1A96BA0BC4E8"><enum>(c)</enum><header>Specified inhaler product defined</header><text display-inline="yes-display-inline">For purposes of this section, the term <term>specified inhaler product</term> means any maintenance or reliever or rescue inhalation drug (including inhalation aerosols, metered dose inhalers, dry powder inhalers, inhalation solutions, bronchodialators, and corticosteroids) with a medically accepted indication (as defined in section 1927(k)(6)) for the treatment of asthma or of chronic obstructive pulmonary disease. Such term includes any equipment used in the administration of such drug (such as masks and tubing, spacers, nebulizers, and valve-holding chambers).</text></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></clause><clause id="HDBA97DC0E2E04648985137555D11B4E9"><enum>(ii)</enum><header>Clerical amendment</header><text>The table of contents in section 1 of such Act is amended by inserting after the item relating to section 725 the following new item:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H46CC9D7698374B3DB68941C20E189AB2"><toc regeneration="no-regeneration"><toc-entry level="section" bold="off">Sec. 726. Coverage and cost-sharing
 requirements for specified inhaler products.</toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></clause></subparagraph><subparagraph id="H78B41463043A46C99FC2DA5A42EBB59C" commented="no"><enum>(D)</enum><header>Conforming amendments</header><clause id="H5706F6F4125C4FE996D1515F269288E2" commented="no"><enum>(i)</enum><header>HDHP safe harbor</header><text display-inline="yes-display-inline"><external-xref legal-doc="usc" parsable-cite="usc/26/223">Section 223(c)(2)</external-xref> of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph:</text><quoted-block style="OLC" id="H1B0F20833112466BA3B87602C62FBE8A" display-inline="no-display-inline"><subparagraph id="H633CD40E3A9D4D9CB74325A4A6851C3B" commented="no"><enum>(H)</enum><header>Safe harbor for absence of deductible for specified inhaler
 products</header><text display-inline="yes-display-inline">For plan years beginning on or after January 1, 2026, a plan shall not fail to be treated as a high deductible health plan by reason of failing to have a deductible for specified inhaler products (as defined in section 2799A–11 of the Public Health Service Act).</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></clause><clause id="HFF371A3D59584F379315BEDD74A19257" commented="no"><enum>(ii)</enum><header>Catastrophic plan safe harbor</header><text>Section 1302(e)(1)(B)(i) of the Patient Protection and Affordable Care Act (<external-xref legal-doc="usc" parsable-cite="usc/42/18022">42 U.S.C. 18022(e)(1)(B)(i)</external-xref>) is amended by inserting <quote>or 2799A–11 of the Public Health Service Act</quote> after <quote>section 2713</quote>.</text></clause></subparagraph><subparagraph id="H4A42D8EEE94C4062A51FD38913427C10"><enum>(E)</enum><header>Effective date</header><text>The amendments made by this paragraph shall apply to plan years beginning on or after January 1, 2026.</text></subparagraph></paragraph><paragraph id="HFC11A69EFDFF431D95B670533F1ED69F"><enum>(2)</enum><header>Medicare</header><subparagraph id="HA0FF45EA6AD64A3494877C3BE4F7C805"><enum>(A)</enum><header>Part B</header><text display-inline="yes-display-inline">Section 1833 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395l">42 U.S.C. 1395l</external-xref>) is amended—</text><clause id="HF29CF88163B74216AB2B4B453FCEBA70"><enum>(i)</enum><text>in subsection (a)(1)(S)—</text><subclause id="HF6559C07896449B79A116DC1F58A050A"><enum>(I)</enum><text>in clause (i), by inserting <quote>or (iii)</quote> after <quote>clause (ii)</quote>; and</text></subclause><subclause id="H88C5F33B15F044A29DFB99C12AB0DD47"><enum>(II)</enum><text>by adding at the end the following new clause: <quote>and (iii) with respect to a specified inhaler product (as defined in section 2799A–11 of the Public Health Service Act) furnished on or after January 1, 2026, the amounts paid shall be 100 percent of the lesser of the actual charge or the payment amount established in section 1842(o) (or, if applicable, under section 1847, 1847A, or 1847B), less, per 30-day supply of such product, $15,</quote>; and</text></subclause></clause><clause id="HBC521519A97942949E1F21C9BCD3D7C9"><enum>(ii)</enum><text>in subsection (b), in the first sentence—</text><subclause id="H4B9C1B253C254F7F97FE4DD7262561CF"><enum>(I)</enum><text>in paragraph (12), by striking <quote>, and</quote>; and</text></subclause><subclause id="H897822516D0C452489763855F5BA02D8"><enum>(II)</enum><text>by striking <quote>..</quote> and inserting <quote>, and (14) such deductible shall not apply with respect to a specified inhaler product (as defined in section 2799A–11 of the Public Health Service Act) furnished on or after January 1, 2026.</quote>.</text></subclause></clause></subparagraph><subparagraph id="H122BDD34DAF3421B8A664761F70AE340"><enum>(B)</enum><header>Part D</header><clause id="H79297686FBBC46B7A91B5DA7DCE23942"><enum>(i)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1860D–2(b) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102(b)</external-xref>) is amended—</text><subclause id="H92D7DBAC901A4770A01091312B3B7483"><enum>(I)</enum><text>in paragraph (1)(A), by striking <quote>paragraphs (8) and (9)</quote> and inserting <quote>paragraphs (8), (9), and (10)</quote>;</text></subclause><subclause id="H242E880DD828425396B7124906713444"><enum>(II)</enum><text>in paragraph (2)(A), by striking <quote>paragraphs (8) and (9)</quote> and inserting <quote>paragraphs (8), (9), and (10)</quote>;</text></subclause><subclause id="H2252396B433D4F3EA75734C46AF40085"><enum>(III)</enum><text>in paragraph (4)(A)(i), by striking <quote>paragraphs (8) and (9)</quote> and inserting <quote>paragraphs (8), (9), and (10)</quote>; and</text></subclause><subclause id="H535852CF0A184A05ABE8B7777D0EA397"><enum>(IV)</enum><text>by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H87DCB8AA2DB94CB6B87B1366913F67A9" display-inline="no-display-inline"><paragraph id="HE681EF7B00DB40CBB93AFF34EE12DA0A"><enum>(10)</enum><header>Treatment of cost sharing for specified inhaler products</header><subparagraph id="HF98F84490C0044A09B586E000B00506B"><enum>(A)</enum><header>No application of deductible</header><text display-inline="yes-display-inline">For plan year 2026 and subsequent plan years, the deductible under paragraph (1) shall not apply with respect to any specified inhaler product.</text></subparagraph><subparagraph id="H43E5479B078649CCBD8DAA6483BB8B49"><enum>(B)</enum><header>Application of cost sharing</header><text display-inline="yes-display-inline">For plan year 2026 and subsequent plan years, the coverage provides benefits for any specified inhaler product with cost sharing for a month’s supply that does not exceed $15.</text></subparagraph><subparagraph id="HE31C37E56ED14E04B8727E6F5236738A"><enum>(C)</enum><header>Definition</header><text>For purposes of this paragraph, the term <term>specified inhaler product</term> has the meaning given such term in section 2799A–11 of the Public Health Service Act. </text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subclause></clause><clause id="H6B0EE11964A04D29AE328B227076C4BB"><enum>(ii)</enum><header>Conforming amendment for alternative prescription drug coverage</header><text display-inline="yes-display-inline">Section 1860D–2(c) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-102">42 U.S.C. 1395w–102(c)</external-xref>) is amended by adding at the end the following new paragraph:</text><quoted-block style="OLC" id="H6EBA058B3E8A4424BBA6C9835B155A6F" display-inline="no-display-inline"><paragraph id="HEDC30DD962544471BBAD24B4ED240418"><enum>(7)</enum><header>Treatment of cost sharing for specified insulin products</header><text display-inline="yes-display-inline">The coverage to provided in accordance with subsection (b)(10).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></clause><clause id="H7D59C2589DD3437187062792AA40C5A0"><enum>(iii)</enum><header>Conforming amendments to cost sharing for low-income individuals</header><text display-inline="yes-display-inline">Section 1860D–14(a) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-114">42 U.S.C. 1395w–114(a)</external-xref>) is amended—</text><subclause id="H01B617CD6B9A4C84B9C312066165A6DD"><enum>(I)</enum><text>in paragraph (1)—</text><item id="HBEC2FB110F1249A2B091C9EF3CD38E4B"><enum>(aa)</enum><text display-inline="yes-display-inline">in subparagraph (D)(iii), by adding at the end the following new sentence: <quote>For plan year 2026 and subsequent plan years, the copayment amount applicable under the preceding sentence to a month's supply of a specified inhaler product (as defined in section 1860D–2(b)(10)) dispensed to the individual may not exceed $15.</quote>; and</text></item><item id="H1349BE4DA02A455F8FB1603BDEB5F549"><enum>(bb)</enum><text>in subparagraph (E), by inserting <quote>or under section 1860D–2(b)(10) in the case of a specified inhaler product (as defined in such section)</quote> after <quote>(as defined in subparagraph (C) of such section)</quote>; and</text></item></subclause><subclause id="H39AE57544E374DFD99865F76A8D832CC"><enum>(II)</enum><text>in paragraph (2)(B), by striking <quote>paragraphs (8) and (9)</quote> and inserting <quote>paragraphs (8), (9), and (10)</quote>.</text></subclause></clause></subparagraph></paragraph></subsection><subsection id="HB09C724C67444B5388BDAB1421EE5BAA"><enum>(b)</enum><header>Payment program for uninsured individuals</header><text>Part P of title III of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/280g">42 U.S.C. 280g et seq.</external-xref>) is amended by adding at the end the following new section:</text><quoted-block style="OLC" id="H91BE2978BB764AE5BC9B238395F42264" display-inline="no-display-inline"><section id="H6428D0711C01490A8BA7883E67BD5AC0" display-inline="no-display-inline" section-type="subsequent-section"><enum>399V–8.</enum><header>Specified inhaler product payment program</header><subsection id="HC4F7008891974C3695DAF344C943CE9A"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Beginning January 1, 2026, the Secretary shall establish a program under which—</text><paragraph id="H92B47A99E1DC450A9DE71567C5B53473"><enum>(1)</enum><text display-inline="yes-display-inline">program-registered providers submit claims to the Secretary with respect to the furnishing of specified inhaler products (as defined in subsection (b)) to uninsured individuals; and</text></paragraph><paragraph id="H4A839F7865874518A2547CDCB80C9E0D"><enum>(2)</enum><text>the Secretary, subject to the availability of appropriations, pays each such provider for such products in an amount determined appropriate by the Secretary.</text></paragraph></subsection><subsection id="HE01EF30109A0429CB344D3AE4720794A"><enum>(b)</enum><header>Definitions</header><text>In this section:</text><paragraph id="H52A59FE21A0F4E00BC8BB7126BC14B95"><enum>(1)</enum><header>Program-registered provider</header><text>The term <term>program-registered provider</term> means a health care provider that—</text><subparagraph id="HF5A9F314054E4C67B78A6B46062ACEFB"><enum>(A)</enum><text display-inline="yes-display-inline">is licensed or otherwise authorized to administer or dispense specified inhaler products in the State in which such provider so administers or dispenses such products under the program established under this section; and</text></subparagraph><subparagraph id="H5BC02AAFE66242129556E1EBB133FC67"><enum>(B)</enum><text>enters into an agreement with the Secretary under which the provider agrees not to hold an uninsured individual liable for the cost of any such product administered or dispensed to such individual in an amount exceeding $15 for a month’s supply of such product if a payment is made under subsection (a)(2) with respect to such product so administered or dispensed.</text></subparagraph></paragraph><paragraph id="H57FAA0A76FB24FD097049A11CB46252C"><enum>(2)</enum><header>Specified inhaler product</header><text>The term <term>specified inhaler product</term> has the meaning given such term in section 2799A–11.</text></paragraph><paragraph id="HF6311543F7AF40FF8113F7392A863615"><enum>(3)</enum><header>Uninsured individual</header><text display-inline="yes-display-inline">The term <term>uninsured individual</term> means, with respect to an individual furnished a specified inhaler product, an individual who is not enrolled in—</text><subparagraph id="H390F72CB650A4B4BBD0B09AAFEE4773F" display-inline="no-display-inline"><enum>(A)</enum><text>a Federal health care program (as defined in section 1128B(f) of the Social Security Act);</text></subparagraph><subparagraph id="HED12F247E0034B2696593981095F838D"><enum>(B)</enum><text>a group health plan or health insurance coverage offered by a health insurance issuer in the group or individual market (as such terms are defined in section 2791); or</text></subparagraph><subparagraph id="H206EAC10A89047AFA4275110C0BECBFB"><enum>(C)</enum><text>a health plan offered under <external-xref legal-doc="usc-chapter" parsable-cite="usc-chapter/5/89">chapter 89</external-xref> of title 5, United States Code.</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="HD61B8B9EC142419AA9B55BCA0E5A6F7B"><enum>(c)</enum><header>Implementation</header><text>The Secretary of Health and Human Services may implement the amendments made by this section by program instruction, subregulatory guidance, or otherwise.</text></subsection></section></legis-body></bill> 

